Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab.

about

Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation The continuing evolution of targeted therapy for inflammatory skin disease.

P2860

Q37331160-8336B4B3-46CE-4ACE-BF92-35B4622858B4 Q38596134-85F0BCA2-0CF3-455E-8CB4-91910AD6CD07

P2860

Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab.

Item

http://www.wikidata.org/entity/Q53436079

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Fulminant skin GvHD with a cyt ...... ression including tocilizumab.

@en

Fulminant skin GvHD with a cyt ...... ression including tocilizumab.

@nl

type

Item

label

Fulminant skin GvHD with a cyt ...... ression including tocilizumab.

@en

Fulminant skin GvHD with a cyt ...... ression including tocilizumab.

@nl

prefLabel

Fulminant skin GvHD with a cyt ...... ression including tocilizumab.

@en

Fulminant skin GvHD with a cyt ...... ression including tocilizumab.

@nl

P1476

Fulminant skin GvHD with a cyt ...... ression including tocilizumab.

@en

P2093

Marie L Reß

http://www.w3.org/2001/XMLSchema#string

Matthias Braun

http://www.w3.org/2001/XMLSchema#string

Matthias Wölfl

http://www.w3.org/2001/XMLSchema#string

Oliver Andres

http://www.w3.org/2001/XMLSchema#string

Paul G Schlegel

http://www.w3.org/2001/XMLSchema#string

Young E Yoo

http://www.w3.org/2001/XMLSchema#string

Yuliya Hellwig

http://www.w3.org/2001/XMLSchema#string

P2860

Elafin is a biomarker of graft-versus-host disease of the skin

Chimeric antigen receptor T cells for sustained remissions in leukemia

Tocilizumab for the treatment of steroid refractory graft-versus-host disease.

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.

IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

Effective use of tocilizumab for the treatment of steroid-refractory gastrointestinal acute graft versus host disease in a child with very high levels of serum interleukin-6.

P304

2033-2035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25595

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279992071

http://www.w3.org/2001/XMLSchema#string

P698

26153219

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab.

about

P2860

P2860

Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921